Metraipolis › archive › dc_3fdd34f97d05

Anti-apoC-III Therapies and Implications for Treatment of Pancreatitis and Cardiovascular Disease — Europe PMC PMID:41082023

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41082023
DOI
10.1007/s11883-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-11-09T09:32:03.075Z
SHA-256 of the archived text
6164659bcdca6c8d153afddb248bb4719691573cf9a0c29ac62c4c47253d7949
Stable URL of this page
https://metraipolis.com/documento/dc_3fdd34f97d05

How to cite

Anti-apoC-III Therapies and Implications for Treatment of Pancreatitis and Cardiovascular Disease — Europe PMC PMID:41082023 — Europe PMC (en), https://europepmc.org/article/MED/41082023 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3fdd34f97d05 (Metraipolis archive dc_3fdd34f97d05, sha256 6164659bcdca6c8d153afddb248bb4719691573cf9a0c29ac62c4c47253d7949)
BibTeX
@misc{dc3fdd34f97d05,
  title = {Anti-apoC-III Therapies and Implications for Treatment of Pancreatitis and Cardiovascular Disease — Europe PMC PMID:41082023},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41082023},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3fdd34f97d05; sha256 6164659bcdca6c8d153afddb248bb4719691573cf9a0c29ac62c4c47253d7949},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41082023. Agents can read the archived copy with the MCP tool read_document.